WGS
GeneDx Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
WGS fundamentals
GeneDx Holdings (WGS) released its earnings on Oct 28, 2025: revenue was 116.70M (YoY +52.35%), beat estimates; EPS was 0.49 (YoY +222.50%), beat estimates.
Revenue / YoY
116.70M
+52.35%
EPS / YoY
0.49
+222.50%
Report date
Oct 28, 2025
WGS Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 revenue up 52% YoY to $116.7 million, with exome/genome revenue surging 66%.
- Strategic Expansion: Doubling sales force to target 60,000 pediatricians, with first reps hired.
- FDA Milestone: Breakthrough designation for ExomeDx and GenomeDx, reinforcing gold-standard status.
- Profitability: 74% gross margin, $14.7 million net income, and $0.51 EPS despite $71 million in strategic investments.
- Newborn Screening: Florida and NIH initiatives aim to diagnose 3% of newborns with actionable conditions.
EPS
Revenue
Revenue & Expenses
WGS has released its 2025 Q3 earnings report, with revenue of 116.74M, reflecting a YoY change of 51.86%, and net profit of -7.63M, showing a YoY change of 8.14%. The Sankey diagram below clearly presents WGS's revenue sources and cost distribution.
Key Indicators
GeneDx Holdings (WGS) key financial stats and ratios, covering profitability, financial health, and leverage.
GeneDx Holdings (WGS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
GeneDx Holdings (WGS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
GeneDx Holdings (WGS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does GeneDx Holdings (WGS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track GeneDx Holdings (WGS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is GeneDx Holdings's gross profit margin?What factors drove the changes in GeneDx Holdings's revenue and profit?What guidance did GeneDx Holdings's management provide for the next earnings period?What is the revenue and EPS growth rate for GeneDx Holdings year over year?What is the market's earnings forecast for GeneDx Holdings next quarter?Did GeneDx Holdings beat or miss consensus estimates last quarter?What were the key takeaways from GeneDx Holdings's earnings call?What does GeneDx Holdings do and what are its main business segments?
